About Colon CFR: Publications

Publications as of February 2012

2012

Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M, Brenner H, Frank B, Bézieau S, KÃ¼ry S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G. Meta-analysis of new genome-wide association studies of colorectal cancer risk . Hum Genet. 2012 Feb;131(2):217-34.

2011

Adams SV, Newcomb PA, Burnett-Hartman AN, White E, Mandelson MT, Potter JD. Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps . Nutr Cancer. 2011 Apr;63(3):319-26.
Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham ET, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2011 Jun;22(6):1420-6.
Borgida AE, Ashamalla S, Al-Sukhni W, Rothenmund H, Urbach D, Moore M, Cotterchio M, Gallinger S. Management of pancreatic adenocarcinoma in Ontario, Canada: a population-based study using novel case ascertainment . Can J Surg. 2011 Feb;54(1):54-60.
Burnett-Hartman AN, Newcomb PA, Mandelson MT, Adams SV, Wernli KJ, Shadman M, Wurscher MA, Makar KW. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms . Nutr Cancer. 2011 May;63(4):583-92.
Cicek MS, Lindor NM, Gallinger S, Bapat B, Hopper JL, Jenkins MA, Young J, Buchanan D, Walsh MD, Le Marchand L, Burnett T, Newcomb PA, Grady WM, Haile RW, Casey G, Plummer SJ, Krumroy LA, Baron JA, Thibodeau SN. Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors Results from the Colon Cancer Family Registry . J Mol Diagn. 2011 May;13(3):271-81.
Coghill AE, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM. Genetic variation in inflammatory pathways is related to colorectal cancer survival . Clin Cancer Res. 2011 Nov 15;17(22):7139-47.
Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer. 2011 Mar 1;104(5):763-8.
Esplen MJ, Stuckless N, Wong J, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV. Development and Validation of an Instrument to Measure the Impact of Genetic Testing on Self-Concept in Lynch Syndrome (LS). Clin Genet. 2011 Aug 26. [Epub ahead of print]
Figueiredo JC, Lewinger JP, Song C, Campbell PT, Conti DV, Edlund CK, Duggan DJ, Rangrej J, Lemire M, Hudson T, Zanke B, Cotterchio M, Gallinger S, Jenkins M, Hopper J, Haile R, Newcomb P, Potter J, Baron JA, Marchand LL, Casey G. Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):758-66.
Jenkins MA, Gurrin LC, Parry S, Win AK. Kaplan-Meier failure estimate for metachronous colorectal cancer risk is clinically relevant . Gut. 2011 Oct 24. [Epub ahead of print]
Kastrinos F, Steyerberg EW, Mercado R, Balmaña J, Holter S, Gallinger S, Siegmund KD, Church JM, Jenkins MA, Lindor NM, Thibodeau SN, Burbidge LA, Wenstrup RJ, Syngal S. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history . Gastroenterology. 2011 Jan;140(1):73-81.
Koo M, Tucker A. Cotterchio M, Kreiger N, McLaughlin J, Gallinger S. Randomized controlled trial of the use of an educational cancer website to increase cancer patient's participation into a research study. Asian Journal of Arts and Sciences. 2011; 1:17-28
Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, Casey G, Woods MO, Thibodeau SN, Lindor NM. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer . Clin Gastroenterol Hepatol. 2011 Jun;9(6):497-502.
Lindor NM, Petersen GM, Spurdle AB, Thompson B, Goldgar DE, Thibodeau SN. Pancreatic cancer and a novel MSH2 germline alteration . Pancreas. 2011 Oct;40(7):1138-40.
Lowery JT, Marcus A, Kinney A, Bowen D, Finkelstein DM, Horick N, Garrett K, Haile R, Sandler R, Ahnen DJ. The Family Health Promotion Project (FHPP): Design and baseline data from a randomized trial to increase colonoscopy screening in high risk families . Contemp Clin Trials. 2011 Nov 12. [Epub ahead of print]
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, Newcomb PA, Le Marchand L, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery . Gut. 2011 Jul;60(7):950-7. Epub 2010 Dec 30.
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, Newcomb PA, Le Marchand L, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery . Gut. 2011 Jul;60(7):950-7.
Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA. Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women . Genes Chromosomes Cancer. 2011 Nov;50(11):875-86.
Petersen HV, Domanska K, Bendahl PO, Wong J, Carlsson C, Bernstein I, Esplen MJ, Nilbert M. Validation of a self-concept scale for Lynch syndrome in different nationalities . J Genet Couns. 2011 Jun;20(3):308-13.
Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: The Seattle Colon Cancer Family Registry . Cancer. 2011 Nov 1;117(21):4948-57.
Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice . Gut. 2011 Jan;60(1):116-29.
Rawson JB, Manno M, Mrkonjic M, Daftary D, Dicks E, Buchanan DD, Younghusband HB, Parfrey PS, Young JP, Pollett A, Green RC, Gallinger S, McLaughlin JR, Knight JA, Bapat B. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients . Carcinogenesis. 2011 May;32(5):741-7.
Rumilla K, Schowalter KV, Lindor NM, Thomas BC, Mensink KA, Gallinger S, Holter S, Newcomb PA, Potter JD, Jenkins MA, Hopper JL, Long TI, Weisenberger DJ, Haile RW, Casey G, Laird PW, Le Marchand L, Thibodeau SN. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated lynch syndrome cases . J Mol Diagn. 2011 Jan;13(1):93-9.
van Vliet CM, Dowty JG, van Vliet JL, Smith L, Mead LJ, Macrae FA, St John DJ, Giles GG, Southey MC, Jenkins MA, Velan GM, Hopper JL. Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes . Hum Mutat. 2011 Feb;32(2):207-12.
Ward CJ, Wu Y, Johnson RA, Woollard JR, Bergstralh EJ, Cicek MS, Bakeberg J, Rossetti S, Heyer CM, Petersen GM, Lindor NM, Thibodeau SN, Harris PC, Torres VE, Hogan MC, Boardman LA. Germline PKHD1 mutations are protective against colorectal cancer . Hum Genet. 2011 Mar;129(3):345-9.
Watkins KE, Way CY, Fiander JJ, Meadus RJ, Esplen MJ, Green JS, Ludlow VC, Etchegary HA, Parfrey PS. Lynch syndrome: barriers to and facilitators of screening and disease management . Hered Cancer Clin Pract. 2011 Sep 7;9:8
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L, Parry S, Thibodeau SN, Haile RW, Gallinger S, Le Marchand L, Lindor NM, Newcomb PA, Hopper JL, Jenkins MA. Body Mass Index in Early Adulthood and Endometrial Cancer Risk for Mismatch Repair Gene Mutation Carriers . Obstet Gynecol. 2011 Apr;117(4):899-905.
Win AK, Dowty JG, English DR, Campbell PT, Young JP, Winship I, Macrae FA, Lipton L, Parry S, Young GP, Buchanan DD, MartÃnez ME, Jacobs ET, Ahnen DJ, Haile RW, Casey G, Baron JA, Lindor NM, Thibodeau SN, Newcomb PA, Potter JD, Le Marchand L, Gallinger S, Hopper JL, Jenkins MA. Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes . Br J Cancer. 2011 Jun 28;105(1):162-9.
Win AK, Hopper JL, Jenkins MA. Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis . Fam Cancer. 2011 Mar;10(1):1-9.
Win AK, Jenkins MA, Buchanan DD, Clendenning M, Young JP, Giles GG, Goldblatt J, Leggett BA, Hopper JL, Thibodeau SN, Lindor NM. Determining the frequency of de novo germline mutations in DNA mismatch repair genes . J Med Genet. 2011 Aug;48(8):530-4.

2010

Anic GM, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Egan KM. Sleep duration and obesity in a population-based study . Sleep Med. 2010 May;11(5):447-51.
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH; Dutch Lynch Syndrome Study Group, Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA. Risks of Lynch syndrome cancers for MSH6 mutation carriers . J Natl Cancer Inst. 2010 Feb 3;102(3):193-201.
Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington MK, Trobridge P, Henikoff S, Grady WM. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model . Mol Carcinog. 2010 Jan;49(1):94-103.
Brevik A, Joshi AD, Corral R, Onland-Moret NC, Siegmund KD, Le Marchand L, Baron JA, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat . Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3167-73.
Buchanan DD, Roberts A, Walsh MD, Parry S, Young JP. Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer . Future Oncol. 2010 Apr;6(4):539-49.
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ, Roberts A, Pearson SA, Pavluk E, Hopper JL, Gattas MR, Goldblatt J, George J, Suthers GK, Phillips KD, Woodall S, Arnold J, Tucker K, Muir A, Field M, Greening S, Gallinger S, Perrier R, Baron JA, Potter JD, Haile R, Frankel W, de la Chapelle A, Macrae F, Rosty C, Walker NI, Parry S, Young JP. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics . PLoS One. 2010 Jul 16;5(7):e11636.
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, Roberts A, Young A, Hampel H, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Chow E, Parry S, Woodall S, Tucker K, Muir A, Field M, Greening S, Gallinger S, Green J, Woods MO, Spaetgens R, de la Chapelle A, Macrae F, Walker NI, Jass JR, Young JP. Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study . Int J Colorectal Dis. 2010 Jun;25(6):703-12.
Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, MartÃnez ME; Colon Cancer Family Registry. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status . J Natl Cancer Inst. 2010 Mar 17;102(6):391-400.
Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk . Am J Epidemiol. 2010 Nov 1;172(9):1000-14.
Conerly M, Grady WM. Insights into the role of DNA methylation in disease through the use of mouse models . Dis Model Mech. 2010 May-Jun;3(5-6):290-7.
Figueiredo JC, Levine AJ, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter J, Limburg PJ, Hopper J, Jenkins MA, Le Marchand L, Baron JA, Haile RW. Genes involved with folate uptake and distribution and their association with colorectal cancer risk . Cancer Causes Control. 2010 Apr;21(4):597-608.
Fridley BL, Serie D, Jenkins G, White K, Bamlet W, Potter JD, Goode EL. Bayesian mixture models for the incorporation of prior knowledge to inform genetic association studies . Genet Epidemiol. 2010 Jul;34(5):418-26.
Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Jenkins M, Young J, Buchanan D, Gallinger S, Adams M, Lewis S, Willis J, Elston R, Markowitz SD, Wiesner GL. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22 . Cancer Res. 2010 Jul 1;70(13):5409-18.
Jacobs ET, MartÃnez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW, LeRoy EC, Poynter JN, Thompson PA, Baron JA. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry . Carcinogenesis. 2010 Aug;31(8):1412-6.
Jenkins MA, Dowty JG, Hopper JL, Tucker K, Southey MC. Letter in response to "Identifying Lynch syndrome" by de la Chapelle et al . Int J Cancer. 2010 Jun 1;126(11):2757-8.
Kohonen-Corish M, Weber TK, Lindblom A, Macrae F; Meeting Participants. Report of the combined meeting of the International Society for Gastrointestinal Hereditary Tumours, the Human Variome Project and the National Cancer Institute Colon Cancer Family Registry, Duesseldorf, Germany, 24 June 2009 . Fam Cancer. 2010 Dec;9(4):705-11.
Levine AJ, Figueiredo JC, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Le Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk . Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1812-21.
Levine AJ, Figueiredo JC, Lee W, Poynter JN, Conti D, Duggan DJ, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Le Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry . Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):89-100.
Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes . J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22.
Lindor NM, Rabe KG, Petersen GM, Chen H, Bapat B, Hopper J, Young J, Jenkins M, Potter J, Newcomb P, Templeton A, Lemarchand L, Grove J, Burgio MR, Haile R, Green J, Woods MO, Seminara D, Limburg PJ, Thibodeau SN. Parent of origin effects on age at colorectal cancer diagnosis . Int J Cancer. 2010 Jul 15;127(2):361-6.
Lindor NM, Yang P, Evans I, Schowalter K, De Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B, Hopper J, Jass J, Jenkins M, Templeton A, Potter J, Newcomb PA, Lemarchand L, Grove J, Haile R, Baron J, Seminara D, Limburg P, Thibodeau SN. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry . Mol Genet Metab. 2010 Feb;99(2):157-9.
McGowan E, Prapavessis H. Colon cancer information as a source of exercise motivation in first- and second-degree relatives of colon cancer patients. Psychology, Health, & Medicine. 15(6), 729-741.
Mrkonjic M, Roslin NM, Greenwood CM, Raptis S, Pollett A, Laird PW, Pethe VV, Chiang T, Daftary D, Dicks E, Thibodeau SN, Gallinger S, Parfrey PS, Younghusband HB, Potter JD, Hudson TJ, McLaughlin JR, Green RC, Zanke BW, Newcomb PA, Paterson AD, Bapat B. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer . PLoS One. 2010 Oct 13;5(10):e13314.
Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P, Parry S, Hopper JL, Haile R, Jenkins MA. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma . Int J Cancer. 2010 Jun 7. [Epub ahead of print]
Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, Potter JD, Baron JA, Frazier ML, Amos CI. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center . Clin Cancer Res. 2010 Feb 15;16(4):1331-9.
Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu XO, Thomas G, TjÃ¸nneland A, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF Jr, Hoover RN, Hartge P, Chanock SJ. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 . Nat Genet. 2010 Mar;42(3):224-8. Epub 2010 Jan 24.
Poynter JN, Jacobs ET, Figueiredo JC, Lee WH, Conti DV, Campbell PT, Levine AJ, Limburg P, Le Marchand L, Cotterchio M, Newcomb PA, Potter JD, Jenkins MA, Hopper JL, Duggan DJ, Baron JA, Haile RW. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry . Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):525-36.
Ramsey S, Blough D, McDermott C, Clarke L, Bennett R, Burke W, Newcomb P. Will Knowledge of Gene-based Colorectal Cancer Disease Risk Influence Quality of Life and Screening Behavior? Findings from a Population-based Study . Public Health Genomics. 2010 Jan 1;13(1):nihpa102310.
Ramsey SD, Wilschut J, Boer R, van Ballegooijen M. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs . Am J Gastroenterol. 2010 Aug;105(8):1861-9.
Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD, Young BW, Jass JR, Rosty C, Gattas M, Pelzer E, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Parry S, Woodall S, Arnold J, Tucker K, Muir A, Drini M, Macrae F, Newcomb P, Potter JD, Pavluk E, Lindblom A, Young JP. Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). Fam Cancer. 2010 Dec 17. [Epub ahead of print]
Royce SG, Alsop K, Haydon A, Mead L, Smith LD, Tesoriero AA, Giles GG, Jenkins MA, Hopper JL, Southey MC. The role of SMAD4 in early-onset colorectal cancer . Colorectal Dis. 2010 Mar;12(3):213-9.
Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, Sinicrope F, Gallinger S. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer . J Clin Oncol. 2010 Jul 10;28(20):3219-26.
Shah NB, Lindor NM. Lower gastrointestinal tract cancer predisposition syndromes . Hematol Oncol Clin North Am. 2010 Dec;24(6):1229-52.
Squires J, Roebothan B, Buehler S, Sun Z, Cotterchio M, Younghusband B, Dicks E, Mclaughlin JR, Parfrey PS, Wang PP. Pickled meat consumption and colorectal cancer (CRC): a case-control study in Newfoundland and Labrador, Canada . Cancer Causes Control. 2010 Sep;21(9):1513-21. Epub 2010 May 27.
Theodoratou E, Campbell H, Tenesa A, Houlston R, Webb E, Lubbe S, Broderick P, Gallinger S, Croitoru EM, Jenkins MA, Win AK, Cleary SP, Koessler T, Pharoah PD, KÃ¼ry S, BÃ©zieau S, Buecher B, Ellis NA, Peterlongo P, Offit K, Aaltonen LA, Enholm S, Lindblom A, Zhou XL, Tomlinson IP, Moreno V, Blanco I, CapellÃ G, Barnetson R, Porteous ME, Dunlop MG, Farrington SM. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants . Br J Cancer. 2010 Dec 7;103(12):1875-84.
Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M. Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis . Cancer Causes Control. 2010 Dec;21(12):2287-93.
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC, Le Marchand L, Newcomb PA, Haile RW, Lindor NM, Hopper JL, Gallinger S, Jenkins MA. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer . Int J Cancer. 2010 Dec 17. [Epub ahead of print]
Win AK, Hopper JL, Jenkins MA. Estimates of familial risks from family data are biased when ascertainment of families is not independent of family history . Gut. 2010 Oct 21. [Epub ahead of print]
Young JP, Parry S. Risk factors: Hyperplastic polyposis syndrome and risk of colorectal cancer . Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):594-5.
Zheng Y, Heagerty PJ, Hsu L, Newcomb PA. On combining family-based and population-based case-control data in association studies . Biometrics. 2010 Feb 16. [Epub ahead of print]

2009

Arnold S, Buchanan DD, Barker M, Jaskowski L, Walsh MD, Birney G, Woods MO, Hopper JL, Jenkins MA, Brown MA, Tavtigian SV, Goldgar DE, Young JP, Spurdle AB. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics . Hum Mutat. 2009 May;30(5):757-70.
Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA . Clin Chem. 2009 Aug;55(8):1559-63.
Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D; Colon Cancer Family Registry. The association of tumor microsatellite instability phenotype with family history of colorectal cancer . Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):967-75.
Chak A, Falk G, Grady WM, Kinnard M, Elston R, Mittal S, King JF, Willis JE, Kondru A, Brock W, Barnholtz-Sloan J. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction . Am J Gastroenterol. 2009 Aug;104(8):1913-21.
Choi YH, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, Gallinger S, McLaughlin J, Aronson M, Briollais L. Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the Colorectal Cancer Familial Registry in Ontario . Hered Cancer Clin Pract. 2009 Aug 23;7(1):14.
Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study . Gastroenterology. 2009 Apr;136(4):1251-60.
Jang JH, Cotterchio M, Gallinger S, Knight JA, Daftary D. Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario . Int J Cancer. 2009 Aug 15;125(4):918-25.
Jenkins MA. Role of MSH6 and PMS2 in the dna mismatch repair process and carcinogenesis . Surg Oncol Clin N Am. 2009 Oct;18(4):625-36.
Lindor NM. Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome . Surg Oncol Clin N Am. 2009 Oct;18(4):637-45.
Lindor NM. Hereditary colorectal cancer: MYH-associated polyposis and other newly identified disorders . Best Pract Res Clin Gastroenterol. 2009;23(1):75-87.
Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A. Hormone therapy in relation to survival from large bowel cancer . Cancer Causes Control. 2009 May;20(4):409-16.
Poynter JN, Haile RW, Siegmund KD, Campbell PT, Figueiredo JC, Limburg P, Young J, Le Marchand L, Potter JD, Cotterchio M, Casey G, Hopper JL, Jenkins MA, Thibodeau SN, Newcomb PA, Baron JA; Colon Cancer Family Registry. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status . Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2745-50.
Rojas A, Padidam M, Cress D, Grady WM. TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta . Biochim Biophys Acta. 2009 Jul;1793(7):1165-73.
Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A, Song X, Ulrich CM, Sasazuki T, Shirasawa S, Grady WM. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway . Gastroenterology. 2009 May;136(5):1680-8.e7.
Walsh MD, Buchanan DD, Walters R, Roberts A, Arnold S, McKeone D, Clendenning M, Ruszkiewicz AR, Jenkins MA, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Macrae F, Drini M, Woods MO, Parry S, Jass JR, Young JP. Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis . Fam Cancer. 2009;8(4):313-23.
Wang PP, Dicks E, Gong X, Buehler S, Zhao J, Squires J, Younghusband B, McLaughlin JR, Parfrey PS. Validity of random-digit-dialing in recruiting controls in a case-control study . Am J Health Behav 2009; 33(5):513-520.
Wernli KJ, Wang Y, Zheng Y, Potter JD, Newcomb PA. The Relationship between Gravidity and Parity and Colorectal Cancer Risk . J Womens Health (Larchmt). 2009 Jul 6. [Epub ahead of print]
Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I–III colon cancer: experience in 2 Canadian provinces . J Can Chir, Vol. 52, No 2, avril 2009

2008

Ali M, Kim H, Cleary S, Cupples C, Gallinger S, Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer . Gastroenterology. 2008 Aug;135(2):499-507.
Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus . Cancer Epidemiol Biomarkers Prev 2008 Nov;17(11):2970-9.
Ceballos RM, Newcomb PA, Beasley JM, Peterson S, Templeton A, Hunt JR. Colorectal cancer cases and relatives of cases indicate similar willingness to receive and disclose genetic information . Genet Test 2008 Sep;12(3):415-20.
Chia VM, Newcomb PA, White E, Zheng Y, Potter JD, Lampe JW. Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements . Horm Res 2008;69(5):295-300. Epub 2008 Feb 6.
Cleary SP, Kim H, Croitoru ME, Redston M, Knight JA, Gallinger S, Gryfe R. Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk . Dis Colon Rectum. 2008 Oct;51(10):1467-73.
Clendenning M, Senter L, Hampel H, Robinson KL, Sun S, Buchanan D, Walsh MD, Nilbert M, Green J, Potter J, Lindblom A, de la Chapelle A. A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome . J Med Genet 2008 Jun;45(6):340-5. Epub 2008 Jan 4.
Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey AB, Harper PA. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk . Cancer Epidemiol Biomarkers Prev 2008 Nov;17(11):3098-107.
Cross JT, Poole EM, Ulrich CM. A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia . Pharmacogenomics J 2008 Aug;8(4):237-47. Epub 2008 Jan 15.
English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype . Cancer Epidemiol Biomarkers Prev 2008 Jul;17(7):1774-80.
Govindarajan A, Fraser N, Cranford V, Wirtzfeld D, Gallinger S, Law CH, Smith AJ, Gagliardi AR. Predictors of multivisceral resection in patients with locally advanced colorectal cancer . Ann Surg Oncol 2008 Jul;15(7):1923-30. Epub 2008 May 13.
Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S; Colorectal Cancer Association Study Consortium, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS; CoRGI Consortium, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S; International Colorectal Cancer Genetic Association Consortium, Campbell H, Dunlop MG. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer . Nat Genet 2008 Dec;40(12):1426-35. Epub 2008 Nov 16.
Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, Martínez ME, Ahnen DJ, Sandler RS, Lance P, Stern MC. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways, and colorectal cancer risk . Carcinogenesis. 2009 Mar;30(3):472-9.
Kirchhoff AC, Newcomb PA, Trentham-Dietz A, Nichols HB, Hampton JM. Family history and colorectal cancer survival in women . Fam Cancer. 2008;7(4):287-92.
Kustra R, Shi X, Murdoch DJ, Greenwood CM, Rangrej J. Efficient p-value estimation in massively parallel testing problems . Biostatistics. 2008 Oct;9(4):601-12.
O'Shea AM, Cleary SP, Croitoru MA, Kim H, Berk T, Monga N, Riddell RH, Pollett A, Gallinger S. Pathological features of colorectal carcinomas in MYH-associated polyposis . Histopathology 2008 Aug;53(2):184-94. Epub 2008 Jun 28.
Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, Lindor N, Young J, Jenkins MA, Hopper JL, Baron JA, Buchanan D, Casey G, Levine AJ, Le Marchand L, Gallinger S, Bapat B, Potter JD, Newcomb PA, Haile RW, Laird PW; Colon Cancer Family Registry Investigators. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening . Cancer Epidemiol Biomarkers Prev 2008 Nov;17(11):3208-15.
Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, Dickson BC, Lockwood G, Gallinger S, Egan SE. Activation of Notch signaling in human colon adenocarcinoma . Int J Oncol 2008 Dec;33(6):1223-9.
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations . Gastroenterology 2008 Aug;135(2):419-28. Epub 2008 May 2.
Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Semple C, Clark AJ, Reid FJ, Smith LA, Kavoussanakis K, Koessler T, Pharoah PD, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Schmidt CO, Hampe J, Chang-Claude J, Hoffmeister M, Brenner H, Wilkening S, Canzian F, Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson IP, Kemp Z, Howarth K, Carvajal-Carmona L, Webb E, Broderick P, Vijayakrishnan J, Houlston RS, Rennert G, Ballinger D, Rozek L, Gruber SB, Matsuda K, Kidokoro T, Nakamura Y, Zanke BW, Greenwood CM, Rangrej J, Kustra R, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 . Nat Genet 2008 May;40(5):631-7. Epub 2008 Mar 30.
Velicer CM, Ulrich CM. Vitamin and mineral supplement use among U.S. adults after cancer diagnosis: a systematic review. J Clin Oncol 2008 Feb 1;26(4):665-73.
Zogopoulos G, Jorgensen C, Bacani J, Montpetit A, Lepage P, Ferretti V, Chad L, Selvarajah S, Zanke B, Hudson TJ, Pawson T, Gallinger S. Germline EPHB2 receptor variants in familial colorectal cancer . PLoS ONE. 2008 Aug 6;3(8):e2885.

2007

Boardman LA, Morlan BW, Rabe KG, Petersen GM, Lindor NM, Nigon SK, Goldberg J, Gallinger S. Colorectal Cancer Risks in Relatives of Young-Onset Cases: Is Risk the Same Across All First-Degree Relatives? Clin Gastroenterol Hepatol 2007 Oct;5(10):1195-8.
Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2007 Sep;16(9):1735-44.
Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer. Cancer Causes Control 2007 Sep;18(7):723-33.
Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, Potter JD. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk . Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2697-703.
Esplen MJ, Madlensky L, Aronson M, Rothenmund H, Gallinger S, Butler K, Toner B, Wong J, Manno M, McLaughlin J. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Genet 2007 Nov;72(5):394-401. Epub 2007 Sep 24.
Glanz K, Steffen AD, Taglialatela LA. Effects of colon cancer risk counseling for first-degree relatives. Cancer Epidemiol Biomarkers Prev 2007 Jul;16(7):1485-91.
Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer 2007;6(1):53-62.
Greenwood CM, Rangrej J, Sun L. Optimal selection of markers for validation or replication from genome-wide association studies. Genet Epidemiol 2007 Jul;31(5):396-407.
Jaskowski L, Young J, Jackson L, Arnold S, Barker MA, Walsh MD, Buchanan DD, Holman S, Mensink KA, Jenkins MA, Hopper JL, Thibodeau SN, Jass JR, Spurdle AB. Stability of BAT26 in Lynch syndrome colorectal tumours. Eur J Hum Genet 2007 Feb;15(2):139-41; author reply 141-2.
Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 2007 Jul;133(1):48-56.
Jenkins MA, Southey MC, Giles GG, Hopper JL. Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer. Curr Oncol Rep 2007 May;9(3):202-7.
Kohut K, Manno M, Gallinger S, Esplen MJ. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry. J Med Genet 2007 Jun;44(6):404-7.
Madlensky L, Daftary D, Burnett T, Harmon P, Jenkins M, Maskiell J, Nigon S, Phillips K, Templeton A, Limburg PJ, Haile RW, Potter JD, Gallinger S, Baron JA. Accuracy of Colorectal Polyp Self-Reports: Findings from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2007 Sep;16(9):1898-901.
Moore LE, Bergen AW, Haque KA, Qi Y, Castle P, Chanock SJ, Egan K, Newcomb P, Titus-Ernstoff L, Alguacil J, Rothman N, Garcia-Closas M. Whole genome amplification of buccal cytobrush DNA collected for molecular epidemiology studies . Biomarkers. 2007 May-Jun;12(3):303-12.
Mrkonjic M, Raptis S, Green RC, Monga N, Daftary D, Dicks E, Younghusband HB, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer. Carcinogenesis 2007 Dec;28(12):2575-80.
Naja F, Krieger N, Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007 Aug;21(8):501-6.
Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Lindor N, Potter JD, Templeton AS, Seminara D, Thibodeau S for the Colon Cancer Family Registry. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer. Cancer Epidemiol Biomarkers Prev 2007 Nov;16(11):2331-2343.
Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women . Cancer Res 2007 Aug 1;67(15):7534-9.
Poynter JN, Figueiredo JC, Conti DV, Kennedy K, Gallinger S, Siegmund KD, Casey G, Thibodeau SN, Jenkins MA, Hopper JL, Byrnes GB, Baron JA, Goode EL, Tiirikainen M, Lindor N, Grove J, Newcomb P, Jass J, Young J, Potter JD, Haile RW, Duggan DJ, Le Marchand L; Colon CFR. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry . Cancer Res 2007 Dec 1;67(23):11128-32.
Ramsey SD, Howlader N, Etzioni R, Brown M, Warren J, Newcomb P. Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer. Cancer 2007 Jun 1;109(11):2222-8.
Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MLH1 -93 G>A promoter polymorphism and the risk for microsatellite unstable colorectal cancer. J Natl Cancer Inst 2007 Mar;99(6):463-74.
Rebbeck TR, Khoury MJ, Potter JD. Genetic association studies of cancer: where do we go from here? Cancer Epidemiol Biomarkers Prev 2007 May;16(5):864-5.
Saunders IW, Hannan GN, Brohede J, Giles GG, Jenkins MA, Hopper JL, Southey MC. A range of simple summary genome-wide statistics for detecting genetic linkage using high density marker data. Genet Epidemiol 2007 Sep;31(6):565-76.
Ulrich CM, Potter JD. Folate and cancer--timing is everything. JAMA 2007 Jun 6;297(21):2408-9.
Woods MO, Williams P, Careen A, Edwards L, Bartlett S, McLaughlin JR, Younghusband HB. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 2007 Jul;28(7):669-73.
Yeoman A, Young J, Arnold J, Jass J, Parry S. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J 2007 Nov 30;120(1266):U2827.
Young JP, Jenkins MA, Parry S, Young BW, Nancarrow DJ, English DR, Giles GG, Jass JR. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 2007 Oct;56(10):1453-9.
Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O'Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, Younghusband B, Green R, Green J, Porteous ME, Campbell H, Blanche H, Sahbatou M, Tubacher E, Bonaiti-Pellié C, Buecher B, Riboli E, Kury S, Chanock SJ, Potter J, Thomas G, Gallinger S, Hudson TJ, Dunlop MG. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007 Aug;39(8):989-94.
Zogopoulos G, Ha KC, Naqib F, Moore S, Kim H, Montpetit A, Robidoux F, Laflamme P, Cotterchio M, Greenwood C, Scherer SW, Zanke B, Hudson TJ, Bader GD, Gallinger S. Germ-line DNA copy number variation frequencies in a large North American population. Hum Genet 2007 Nov;122(3-4):345-53.

2006

Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, Giardiello FM, Offit K, Parmigiani G; Colon Cancer Family Registry. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006 Sep 27;296(12):1479-87.
Chia VM, Newcomb PA, Bigler J, Morimoto LM, Thibodeau SN, Potter JD. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use. Cancer Res 2006 Jul 1;66(13):6877-83.
Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006 Dec;136(12):3046-53.
Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 2006 Feb;17(1):63-70.
Esplen MJ. Mapping the human genome: psychosocial impacts and implications for nursing. Can J Nurs Res 2006 Jun;38(2):115-22.
Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St. John DJ, Jass JR, Giles GG, Hopper JL, Southey MC. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 2006 Apr;4(4):489-98.
Jenkins M, Croitoru M, Monga N, Cleary S, Cotterchio M, Hopper J, Gallinger S. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):312-4.
Jenkins MA, Macrae F, Young J, Barker M, Leggett B, Goldblatt J, Kirk J, Tucker K, Suthers G, Young G, Parry S, Arnold J, Winship I, Maskiell J, Giles G, Jass J, Hopper J. The Colon Cancer Family Registry, an international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update 2006;46:14-20.
Jenkins MA, Southey MC, Giles GG, Hopper JL. Rationale for, and approach to studying, modifiers of risk in persons with a genetic predisposition to colorectal cancer. Review Current Colorectal Cancer Reports 2006;2:173-8.
Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006 Sep 27;296(12):1507-17. Review.
Lindor NM, Smalley R, Barker M, Bigler J, Krumroy LM, Lum-Jones A, Plummer SJ, Selander T, Thomas S, Youash M, Seminara D, Casey G, Bapat B, Thibodeau SN. Ascending the learning curve—MSI testing experience of a six-laboratory consortium. Cancer Biomark 2006;2(1-2):5-9.
Pastrello C, Baglioni S, Tibiletti MG, Papi L, Fornasarig M, Morabito A, Agostini M, Genuardi M, Viel A. Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur J Hum Gene 2006 Jan;14(1):63-8
Psaty BM, Potter JD. Editorial: Risks and benefits of celecoxib to prevent recurrent adenomas. N Engl J Med 2006 Aug 31;355(9):950-2.
Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006 Sep;8(9):571-5.
Seary AJ, Richards WD, McKeown-EyssenG, Baines C. Networks of Symptoms and Exposures. Structure and Dynamics: eJournal of Anthropological and Related Sciences: Vol. 1: No. 2, Article 3.
Sinicrope FA, Rego RL, Foster N, Sargent DJ, Windschitl HE, Burgart LJ, Witzig TE, Thibodeau SN. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 2006 Dec;101(12):2818-25. Epub 2006 Oct 6.
Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006 Sep;131(3):729-37.
Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B, French AJ, Allegra CJ, Laurie JA, Goldberg RM, Witzig TE, Thibodeau SN. Thymidylate synthase expression in colon carcinomas with microsatellite instability. Clin Cancer Res 2006 May 1;12(9):2738-44.
Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, French AJ, Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006 Sep;131(3):729-37.
Taylor NP, Powell MA, Gibb RK, Rader JS, Huettner PC, Thibodeau SN, Mutch DG, Goodfellow PJ. MLH3 mutation in endometrial cancer. Cancer Res 2006 Aug 1;66(15):7502-8.
Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, Kakar S, Fridlyand J, Snijders AM, Albertson DG, Thibodeau SN, Waldman FM. Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res 2006 Nov 1;12(21):6379-85.
Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006 Feb;6(2):130-40. Review.
Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW.CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006 Jul;38(7):787-93. Epub 2006 Jun 25.
Yasui Y, Newcomb PA, Trentham-Dietz A, Egan KM. Familial relative risk estimates for use in epidemiologic analyses. Am J Epidemiol 2006 Oct 1;164(7):697-705. Epub 2006 Aug 21.
Young J, Jass JR. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 2006 Oct;15(10):1778-84.
Yu JH, Bigler J, Whitton J, Potter JD, Ulrich CM. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking. Am J Gastroenterol 2006 Jun;101(6):1313-9.

2005

Artinyan A, Essani R, Lake J, Kaiser LAM, Vukasin P, Danenberg P, Danenberg K, Haile R, Beart RW. Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression. JOGS 2005;9:1216-21.
Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer 2005;4(3):255-65. Review.
Baudhuin LM, Mai M, French AJ, Kruckeberg KE, Swanson RL, Winters JL, Courteau LK, Thibodeau SN. Analysis of hMLH1 and hMSH2 gene dosage alterations in hereditary nonpolyposis colorectal cancer patients by novel methods. J Mol Diagn 2005 May;7(2):226-35. [Resource-inspired]
Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, Hopper JL, Diep A, Bapat B, Salem M, Seminara D, et al. for the Colon Cancer Family Registry. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005;293:799-809.
Chia V, Newcomb PA. Environmental risk factors and colorectal neoplasia—recent developments. Current Colorectal Cancer Reports 2005;1(2):67-72.
Coolbaugh-Murphy MI, Xu J, Ramagli LS, Brown BW, Siciliano MJ Microsatellite instability (MSI) increases with age in normal somatic cells. Mech Ageing Dev 2005 Oct;126(10):1051-9.
Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005;16:865-75.
Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 2004; 127:714-722.
Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S. Association between colonic screening, subject characteristics, and stage of colorectal cancer. Am J Gastroenterol 2005 Nov;100(11):2531-9.
Gill S, Lindor NM, Burgart LJ, Smalley R, Leontovich O, French AJ, Goldberg RM, Sargent DJ, Jass JR, Hopper JL, Jenkins MA, Young J, Barker MA, Walsh MD, Ruszkiewicz AR, Thibodeau SN. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 2005 Sep 15;11(18):6466-71.
Gryfe R, Gallinger S. Germline PMS2 mutations: one hit or two? Gastroenterology 2005 May;128(5):1506-9. Review.
Hitchins M, Williams R, Cheong K, Halani N, Lin VA, Packham D, Ku S, Buckle A, Hawkins N, Burn J, Gallinger S, Goldblatt J, Kirk J, Tomlinson I, Scott R, Spigelman A, Suter C, Martin D, Suthers G, Ward R. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer . Gastroenterology. 2005 Nov;129(5):1392-9.
Janes H, Pepe M, Kooperberg C, Newcomb P. Identifying target populations for screening or not screening using logic regression. Stat Med 2005 May 15;24(9):1321-38.
Le Marchand L. The predominance of the environment over genes in cancer causation: implications for genetic epidemiology. Cancer Epidemiol Biomarkers Prev 2005 May;14(5):1037-9.
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 Apr 27;293(16):1979-85.
Morimoto LM, Newcomb PA, Bigler J, White E, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors. Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1394-401.
Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors. (United States). Cancer Causes Control 2005 Oct;16(8):917-27
Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2005 May;14(5):1204-11.
Potter JD. Epidemiology informing clinical practice: from bills of mortality to population laboratories. Nat Clin Pract Oncol 2005 Dec;2(12):625-34.
Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 2005;29:221-6.
Ramsey SD, Burke W, Pinsky L, Clarke L, Newcomb P, Khoury MJ. Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev 2005 Nov;14(11 Pt 1):2494-500.
Thomas BC, Thibodeau SN, Lindor NM. Clinical Significance of tumor microsatellite instability and immunohistochemistry for mismatch repair deficiency in colorectal cancers. Current Colorectal Cancer Reports 2005 Vol 1:no. 1; 1-6.
Thomas DC, Haile RW, Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet 2005 Sep;77(3):337-45.
Woods MO, Hyde AJ, Curtis FK, Stuckless S, Green JS, Pollett AF, Robb JD, Green RC, Croitoru ME, Careen A, Chaulk JA, Jegathesan J, McLaughlin JR, Gallinger SS, Younghusband HB, Bapat BV, Parfrey PS. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin Cancer Res 2005 Oct 1;11(19 Pt 1):6853-61.
Young J, Barker MA, Simms LA, Walsh MD, Biden KG, Buchanan D, Buttenshaw R, Whitehall VL, Arnold S, Jackson L, Kambara T, Spring KJ, Jenkins MA, Walker GJ, Hopper JL, Leggett BA, Jass JR. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005 Mar;3(3):254-63.

2004

Boland CR, Bigler J, Newcomb PA, Lampe JW, Potter JD. Evidence for an association between JC virus and colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2285-6; author reply 2286.
Coolbaugh-Murphy M, Maleki A, Ramagli L, Frazier M, Lichtiger B, Monckton DG, Siciliano MJ, Brown BW. Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR. Genomics 2004 Aug;84(2):419-30.
Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, Redston M, Cotterchio M, Knight J, Gryfe R, Gallinger S. Association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk. J Natl Cancer Inst 2004;96(21):1631-4.
Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espin E, Armengol M, Hamelin R, Yamamoto H, Hofstra RMW, Seruca R, Lindblom A, Peltomaki P, Thibodeau SN, Aaltonen LA, Schwartz S. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004 Sep;41(9):664-8.
Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 2004; 127:714-722.
Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004 Aug;53(8):1137-44.
Kambara T, Whitehall VL, Spring KJ, Barker MA, Arnold S, Wynter CV, Matsubara N, Tanaka N, Young JP, Leggett BA, Jass JR. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 2004;40(1):1-9.
Lindor, NM. Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes. Clin Gastroenterol Hepatol 2004 May;2(5):366-75.
Lindor NM, Sloan J, Goldberg R, Bowen D, Nigon S, Roche A, Petersen G, Thibodeau SN, Burgart L, Leontovich O, Morlan BW. Colorectal tumour microsatellite instability test results: perspectives from patients. Hereditary Cancer Clin Pract 2004;2(2):69-75
Madlensky L, Esplen MJ, Goel V. Reasons given by relatives of colorectal cancer patients for not undergoing screening. Prev Med 2004;39(4):643-8.
McGivern A, Wynter CVA, Whitehall VLJ, Kambara T, Spring KJ, Walsh MD, Barker MA, Arnold S, Simms LA, Leggett BA, Young J, Jass JR. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer 2004;3(2):101-7.
Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A. Mismatch repair gene PMS2: Disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 2004 Jul 15;64(14):4721-7. [Resource-inspired]
Newcomb PA, Bush AC, Stoner GL, Lampe JW, Potter JD, Bigler J. No evidence of an association of JC virus and colon neoplasia. Cancer Epidemiol Biomarkers Prev 2004 Apr;13(4):662-6.
Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004 May 1;159(9):882-90. Review.
Sullivan T, Ashbury FD, Fallone CA, Naja F, Schabas R, Hebert PC, Hunt R, Jones N. Helicobacter pylori and the prevention of gastric cancer. Can J Gastroenterol 2004 May;18(5):295-302.
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004 Feb 18;96(4):261-8.
Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC, French AJ, Johnson RA, Burgart LJ, Rabe K, Lindor NM, Thibodeau SN. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004 Jul;127(1):9-16. Erratum in: Gastroenterology. 2004 Nov;127(5):1651.
Wynter CVA, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancers. Gut 2004; 53, 573-80.

2003

Adem C, Soderberg CL, Cunningham JM, Reynolds C, Sebo TJ, Thibodeau SN, Hartmann LC, Jenkins RB. Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer 2003 Nov 20;107(4):580-2. [Resource-inspired]
Campbell P, Cotterchio M, Klar N, McLaughlin J, Gallinger S. Colorectal cancer risk among post-menopausal hormone users in a population-based familial case-control study. Ann Epidemiol 2003;13(8):562.
Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J. The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. J Psychosom Res 2003;55(5):427-35.
Hahnloser D, Peterson GM, Rabe K, Snow K, Lindor NM, Boardman L, Koch B, Doescher D, Wang L, Steenblock K, Thibodeau SN. The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev 2003;12(10):1023-8.
Jass JR, Barker M, Fraser L, Walsh MD, Whitehall VLJ, Gabrielli B, Young J, Leggett BA. APC mutation and tumour budding in colorectal cancer. J Clin Pathol 2003;56(1):69-73.
Kakar S, Burgart LJ, Thibodeau SN, Rabe KG, Peterson GM, Goldberg RM, Lindor NM. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer 2003;97(6):1421-7.
Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 2003;25(3):187-94.
Madlensky L, McLaughlin J, Goel V. A comparison of self-reported colorectal cancer screening with medical records. Cancer Epidemiol Biomarkers Prev 2003;12(7):656-9.
Morimoto LM, White E, Newcomb PA. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 2003 Aug 1;158(3):259-63.
Nadalin V, Cotterchio M, McKeown-Eyssen G, Gallinger S. Agreement between proxy- and case-reported information obtained using the self-administered Ontario Familial Colon Cancer Registry epidemiologic questionnaire. Chronic Dis Can 2003;24(1):1-8.
Nakagawa H, Lockman JC, Frankel WL, Hampel H, Steenblock K, Burgart LJ, Thibodeau SN, de la Chapelle A. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 2004 Jul 15;64(14):4721-7.
Newcomb PA, Storer B, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95(8):622-25.
Pan K, Liu W, Lu YY, Zhang L, Li Z, Lu WL, Thibodeau SN, You WC. High throughput detection of microsatellite instability by denaturing high-performance liquid chromatography. Hum Mutat 2003 Nov;22(5):388-94.
Ramsey SD, Burke W, Clarke L. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med 2003;5(5):353-63.
Ramsey SD, Wilson S, Spencer A, Geidzinska A, Newcomb PA. Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives, and members of the community Results of focus group interviews. Community Genet 2003;6(1):29-36.
Wang L, Cunningham JM, Winters JL, Guenther JC, French AJ, Boardman LA, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res 2003 Sep 1;63(17):5209-12.
Wright FC, Law CH, Last L, Khalifa M, Arnaout A, Naseer Z, Klar N, Gallinger S, Smith AJ. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 2003;10(8):903-9.
Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003;24(2):190-8.

2002

Blaine S, Carroll J, Esplen MJ. Managing patients with a family history of cancer: psychosocial issues and primary care providers' evolving role in cancer genetics. Primary Psychiatry: Cancer Care Therapy: Psychosocial Issues in Cancer Genetics 2002;9(5):34-8.
Easson AM, Cotterchio M, Crosby JA, Sutherland H, Dale D, Aronson M, Holowaty E, Gallinger S. A population-based study of the extent of surgical resection of potentially curable colon cancer. Ann Surg Oncol 2002;9(4):380-7.
Jass JR, Walsh MD, Barker M, Simms LA, Young BA, Leggett BA. Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability (review). Eur J Cancer 2002;38(7):858-66.
Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20(4):1043-8.
Siegmund KD, Langholz B. Ascertainment bias in family-based case-control studies. Am J Epidemiol 2002;155(9):875-80.
Whitehall VLJ, Wynter CVA, Walsh MD, Simms LA, Purdie D, Pandeya N, Young J, Meltzer SJ, Leggett BA, Jass JR. Morphological and molecular heterogeneity within nonmicrosatellite-high colorectal cancer. Cancer Res 2002;62(21):6011-14.
Young J, Barker M, Fraser L, Walsh MD, Spring K, Biden KG, Simms LA, Leggett BA, Hopper JL, Jass JR. Mutation searching in colorectal cancer studies: experience with a denaturing high pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes. Pathology 2002;34(6):529-33.

2001

Esplen MJ, Madlensky L, Butler K, McKinnon W, Wong J, Gallinger S. Motivations and psychosocial impact associated with genetic testing for HNPCC. Am J Med Genet 2001; 103(1):9-15.
Garcia-Closas M, Egan KM, Abruzzo J, Newcomb PA, Titus-Ernstoff L, Franklin T, Bender PK, Beck JC, Le Marchand L, Lum A, Alavanja M, Hayes RB, Rutter J, Buetow K, Brinton LA, Rothman N. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 2001 Jun;10(6):687-96.
Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev 2001;10(8):869-74.
Le Marchand L, Lum-Jones A, Saltzman B, Visaya V, Nomura AM, Kolonel LN. Feasibility of collecting buccal cell DNA by mail in a cohort study. Cancer Epidemiol Biomarkers Prev 2001 Jun;10(6):701-3.
McIntosh M, Ramsey S, Berry K, Urban N. Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes. Health Econ 2001;10:53-66.
Nadalin V, Cotterchio M, McKeown-Eyssen G, Jazmaji V, Gallinger S. Validity of proxy reports obtained using the Ontario Familial Colon Cancer Registry epidemiologic questionnaire. Am J Epidemiol 2001;153:S88.
Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135(8 Pt 1):577-88.
Siegmund KD, Langholz B. Stratified case sampling and the use of family controls. Genet Epidemiol 2001;20(3):316-27.
Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instabilty. Cancer Res 2001;61(3):827-30.
Young J, Biden KG, Simms LA, Huggard P, Karamatic R, Eyre HJ, Sutherland GR, Herath N, Barker M, Anderson GJ, Fitzpatrick DR, Ramm GA, Jass JR, Leggett BA. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 2001;98(1):265-70.
Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin S-A, Borten MM, Stitz R, Searle J, Mckeone D, Fraser L, Purdie D, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001;159(6):2107-16.

2000

Biemer-Huttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, Leggett BA, Jass JR. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 2000;6(5):1909-16.
Clouston AD, Clouston DR, Jass JR. Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue . Histopathology. 2000 Dec;37(6):567.
Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, Macey J, Holowaty E, Gallinger S. Ontario familial colon cancer registry: methods and first-year response rates. Chron Dis Can 2000;21(2):81-6.
Jass JR, Constable L, Sutherland R, Winterford C, Walsh MD, Young J, Leggett BA. Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue . Histopathology. 2000 Feb;36(2):116-20.
Jass JR. Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol 2000;1(4):220-6.
Ramsey SD, McIntosh M, Etzioni R, Urban N. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am 2000;14(4):925-38. Review.

1999

Bapat BV, Madlensky L, Temple LKF, Hiruki T, Redston M, Baron DL, Xia L, Soravia C, Mitri A, Shen W, Gryfe R, Berk T, Chodirker B, Cohen Z, Gallinger S. Family history characteristics, tumor microsatellite instability and germline MSH2, and MLH1 mutations in hereditary colorectal cancer. Hum Genet 1999;104(2):167-76.
Glanz K, Grove J, Le Marchand L, Nakamura A, Gotay C. Underreporting of family history of colon cancer: correlates and implications . Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):635-39.
Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups . Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):329-36.
Haile RW, Siegmund KD, Gauderman WJ, Thomas DC. Study-design issues in the development of the University of Southern California Consortium's Colorectal Cancer Family Registry. J Natl Cancer Inst Monogr 1999;(26):89-93.
Le Marchand L, Wilkens LR, Hankin JH, Kolonel LN, Lyu LC.Independent and joint effects of family history and lifestyle on colorectal cancer risk: implications for prevention . Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):45-51.
Le Marchand L. Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans . J Natl Cancer Inst Monogr. 1999;(26):101-5.
Seminara D, ed. Innovative study designs and analytic approaches to the genetic epidemiology of cancer. J Natl Cancer Inst Monogr 1999;(26):1-105. JNCI Web
Siegmund KD, Whittemore AS, Thomas DC. Multistage sampling for disease family registries. J Natl Cancer Inst Monogr 1999;(26):43-8.

1998

Lum A, Le Marchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies . Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):719-24.